Généthon is delighted with the treatment of a first patient as part of a gene therapy trial for the late form of Pompe disease, led by the company SparkTherapeutics and integrating technologies developed at Généthon

Written by Généthon | February 10, 2021 Pompe disease is an inherited genetic disorder linked to alpha-deficiencyglucosidase acid (GAA) which causes glycogen to build up in lysosomes, causing cell damage …

Read more

In Strasbourg, the Greens hostile to Huawei investments

The establishment in the Grand-Est of a 5G antenna factory of the world leader in telecoms equipment will be discussed on Monday. For now, the subject divides opinion. By Yolande …

Read more

“Distrust of the government’s plan calls for institutional reforms”

Antoine Bristielle is an associate professor of social sciences, doctoral student at Sciences Po Grenoble. Tristan Guerra is a doctoral student at Sciences Po Grenoble. When a democratic regime is …

Read more

The Élysée Palace does not rule out reconfiguration in the event of a second epidemic wave after May 11

Édouard Philippe wanted to be both serious and optimistic. At a press conference on the coronavirus on Sunday, the Prime Minister said that “our life, from May 11, it will …

Read more